Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curbifluxx is a nutraceutical supplement developed by Ruhrpharm, containing pumpkin seed oil (*Cucurbita pepo*) as its primary active ingredient. It is marketed for the support of bladder health and the management of urinary symptoms. While the manufacturer does not specify a molecular mechanism of action, pumpkin seed oil is traditionally used to alleviate symptoms associated with urinary tract dysfunction, such as those related to an overactive bladder or benign prostatic hyperplasia (BPH). The therapeutic benefits are generally attributed to the oil's content of phytosterols, tocopherols, and unsaturated fatty acids, which may exert anti-inflammatory effects and help maintain normal urinary flow and bladder function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Curbifluxx.